Skip to main content
SpringerLink
Log in

Prevention and Control of Painful Diabetic Neuropathy

  • Chapter
  • First Online:
Painful Diabetic Polyneuropathy

  • 1339 Accesses

Abstract

Diabetic peripheral neuropathy (DPN), in all its different forms, is the most common long-term diabetes complication, affecting about half of all diabetic patients [1]. The different clinical patterns that develop in diabetic patients are characterized by a remarkable heterogeneity regarding their symptoms, pattern of neurologic involvement, natural history, response to treatment, and pathologic alterations [2, 3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tavee J, Zhou L. Small fiber neuropathy: a burning problem. Cleve Clin J Med. 2009; 76:297–305.

    Article  PubMed  Google Scholar 

  2. Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.

    Article  PubMed  Google Scholar 

  3. Thomas PK. Classification, differential diagnosis and staging of diabetic peripheral neuropathy. Diabetes. 1997;46:S54–7.

    Article  PubMed  CAS  Google Scholar 

  4. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.

    Article  PubMed  CAS  Google Scholar 

  5. Løseth S, Stålberg E, Jorde R, et al. Early diabetic neuropathy: thermal thresholds in patients with normal nerve conduction studies. J Neurol. 2008;255:1197–202.

    Article  PubMed  Google Scholar 

  6. Malavige LS, Levy JC. Erectile dysfunction in diabetes. J Sex Med. 2009;6:1232–47.

    Article  PubMed  Google Scholar 

  7. Vinik AI, Mehrabyan A. Diabetic neuropathies. Med Clin North Am. 2004;88:947–99.

    Article  PubMed  CAS  Google Scholar 

  8. Sima AA, editor. Chronic complication in diabetes. Animal models and chronic complications. Amsterdam: Hardwood Academic Publishers; 2000. p. 1–277.

    Google Scholar 

  9. Kellogg AP, Pop-Busui R. Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress. Antioxid Redox Signal. 2005;7:1521–9.

    Article  PubMed  CAS  Google Scholar 

  10. Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress ant antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care. 2004;27:2178–83.

    Article  PubMed  CAS  Google Scholar 

  11. Ceriello A, Motz E. Is oxidative stress the pathogenetic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24:816–23.

    Article  PubMed  CAS  Google Scholar 

  12. Tirosh A, Shai I, Tekes-Manova D, et al. Normal fasting plasma glucose increases in young men. N Engl J Med. 2005;353:1454–62.

    Article  PubMed  CAS  Google Scholar 

  13. Godsland IF, Jeffs JA, Johnston DG. Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia. 2004;47:1157–66.

    Article  PubMed  CAS  Google Scholar 

  14. Hoffman-Snyder C, Smith BE, Ross MA, et al. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol. 2006;63:1075–9.

    Article  PubMed  Google Scholar 

  15. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001;28:2361–6.

    Google Scholar 

  16. Ochoa JL, Torebjork HE. Paraesthesiae from ectopic impulse generation in human sensory nerves. Brain. 1980;103:835–53.

    Article  PubMed  CAS  Google Scholar 

  17. Kihara M, Low PA. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol. 1995;132:180–5.

    Article  PubMed  CAS  Google Scholar 

  18. Gupta S, Chough E, Daley J, et al. Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity. Am J Physiol Cell Physiol. 2002; 282: C560–6.

    PubMed  CAS  Google Scholar 

  19. Hoffman MA, Kohl B, Zumbach MS, et al. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care. 1998;21:841–8.

    Article  Google Scholar 

  20. Backonja MM, Coe CL, Muller DA, et al. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol. 2008;195:157–63.

    Article  PubMed  CAS  Google Scholar 

  21. Gibbons CH, Freeman R. Treatment induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534–41.

    Article  PubMed  Google Scholar 

  22. Sun WL, Yan JL, Chen LL. Unilateral poluneuropathy involving cranial nerves V, VII, VIII and XII in a diabetic patient. Quintessence Int. 2011;42:873–7.

    PubMed  Google Scholar 

  23. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27:2942–7.

    Article  PubMed  Google Scholar 

  24. Diabetes control and complication trial research group: the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977–86.

    Google Scholar 

  25. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524–34.

    Article  PubMed  Google Scholar 

  26. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988;11:21–32.

    Article  PubMed  CAS  Google Scholar 

  27. Armstrong DG, Lavery LA, Vela SA. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158:289–92.

    Article  PubMed  CAS  Google Scholar 

  28. Feldman EL, Stevens MJ, Thomas PK. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–9.

    Article  PubMed  CAS  Google Scholar 

  29. Meijer JW, Van Sonderen E, et al. Diabetic neuropathy examination: a hierarchical scoring system to diagnose polyneuropathy in diabetes. Diabetes Care. 2000;23:750–3.

    Article  PubMed  CAS  Google Scholar 

  30. Young MJ, Breddy JL, Veves A, et al. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care. 1994;17:557–60.

    Article  PubMed  CAS  Google Scholar 

  31. Smieja M, Hunt DL, Edelman D, et al. Clinical examination for the detection of protective sensation in the feet of diabetic patients. J Gen Intern Med. 1999;14:418–24.

    Article  PubMed  CAS  Google Scholar 

  32. Apfel SC, Asbury AK, Bril V, et al. Ad hoc panel on endpoints for diabetic neuropathy trials. Positive sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci. 2001; 189:3–5.

    Article  PubMed  CAS  Google Scholar 

  33. Wilson JR, Stittsworth JD, Kadir MA, et al. Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy. Muscle Nerve. 1998;21:1228–30.

    Article  PubMed  CAS  Google Scholar 

  34. Caselli A, Rich J, Hanane T, et al. Role of C-nociceptive fibers in the nerve axon reflex-related vasodilatation in diabetes. Neurology. 2003;60:297–300.

    Article  PubMed  CAS  Google Scholar 

  35. Chao CC, Hsieh SC, Yang WS, et al. Glycemic control is related to the severity of impaired thermal sensation in type 2 diabetes. Diabetes Metab Res Rev. 2007;23:612–20.

    Article  PubMed  CAS  Google Scholar 

  36. Bril V, England J, Franklin JM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy. Report of the American Academy of Neurology, the American association of Neuromuscolar and Electrodiagnostic medicine and the American Academy of Physical Medicine and Rehabilitation. Muscle Nerve. 2011;43:910–7.

    Article  PubMed  Google Scholar 

  37. Vinik AI, Strotmeyer ES, Nakave AA, et al. The development and validation of the Norfolk QOL-DN, a new measure of patients’ perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther. 2005;7:497–508.

    Article  PubMed  Google Scholar 

  38. Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131:1912–25. 39.DCCT Research Group. Diabetes Control and Complications Trial (DCCT): update. Diabetes Care. 1990;13:427–33.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetology Section, Department of Medicine, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy

    Alberto Piaggesi M.D., Elisabetta Iacopi M.D. & Valerio Vallini M.D.

Authors
  1. Alberto Piaggesi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabetta Iacopi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valerio Vallini M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto Piaggesi M.D. .

Editor information

Editors and Affiliations

  1. , Department of Anesthesiology, University of California San Diego, Campus Point Dr 9300, La Jolla, 92037, California, USA

    Erin Lawson

  2. , Department of Neurology, University of Wisconsin, Highland Avenue 1685, Madison, 53705-2281, Wisconsin, USA

    Miroslav "Misha" Backonja

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Piaggesi, A., Iacopi, E., Vallini, V. (2013). Prevention and Control of Painful Diabetic Neuropathy. In: Lawson, E., Backonja, M. (eds) Painful Diabetic Polyneuropathy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6299-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6299-6_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6298-9

  • Online ISBN: 978-1-4614-6299-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation